Olive (Olea europaea L.) Leaf Polyphenols Improve Insulin Sensitivity in Middle-Aged Overweight Men: A Randomized, Placebo-Controlled, Crossover Trial
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Olive plant leaves (Olea europaea L.) have been used for centuries in folk medicine to treat diabetes, but there are very limited data examining the effects of olive polyphenols on glucose homeostasis in humans. OBJECTIVE: To assess the effects of supplementation with olive leaf polyphenols (51.1 mg oleuropein, 9.7 mg hydroxytyrosol per day) on insulin action and cardiovascular risk factors in middle-aged overweight men. DESIGN: Randomized, double-blinded, placebo-controlled, crossover trial in New Zealand. 46 participants (aged 46.4 ± 5.5 years and BMI 28.0 ± 2.0 kg/m(2)) were randomized to receive capsules with olive leaf extract (OLE) or placebo for 12 weeks, crossing over to other treatment after a 6-week washout. Primary outcome was insulin sensitivity (Matsuda method). Secondary outcomes included glucose and insulin profiles, cytokines, lipid profile, body composition, 24-hour ambulatory blood pressure, and carotid intima-media thickness. RESULTS: Treatment evaluations were based on the intention-to-treat principle. All participants took >96% of prescribed capsules. OLE supplementation was associated with a 15% improvement in insulin sensitivity (p = 0.024) compared to placebo. There was also a 28% improvement in pancreatic β-cell responsiveness (p = 0.013). OLE supplementation also led to increased fasting interleukin-6 (p = 0.014), IGFBP-1 (p = 0.024), and IGFBP-2 (p = 0.015) concentrations. There were however, no effects on interleukin-8, TNF-α, ultra-sensitive CRP, lipid profile, ambulatory blood pressure, body composition, carotid intima-media thickness, or liver function. CONCLUSIONS: Supplementation with olive leaf polyphenols for 12 weeks significantly improved insulin sensitivity and pancreatic β-cell secretory capacity in overweight middle-aged men at risk of developing the metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Validating the SF-36 health survey questionnaire: new outcome measure for primary care.
Brazier, J. E., Harper, R., Jones, N. M., O'Cathain, A., Thomas, K. J., Usherwood, T., & Westlake, L. (1992) · BMJ · doi:10.1136/bmj.305.6846.160 · Cited by 4,653
Hagströmer, M., Oja, P., & Sjöström, M. (2006) · Public Health Nutrition · doi:10.1079/phn2005898 · Cited by 1,958
Raitakari, O. T., Juonala, M., Kähönen, M., Taittonen, L., Laitinen, T., Mäki-Torkko, N., Järvisalo, M. J., Uhari, M., Jokinen, E., Rönnemaa, T., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2277 · Cited by 1,732
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405 · cited 1×
“Secondary Outcomes Other parameters of glucose homeostasis assessed included pancreatic b-cell function, also calculated from the oral glucose tolerance test: the product of insulin sensitivity (derived by the Matsuda method) and the change in glucose and insulin over the first 30 minutes (oral disposition index) [13].”
MethodCarey, A. L., Steinberg, G. R., Macaulay, S. L., Thomas, W. G., Holmes, A. G., Ramm, G., Prelovsek, O., Hohnen-Behrens, C., Watt, M. J., James, D. E., et al. (2006) · Diabetes · doi:10.2337/db05-1404 · Cited by 898 · cited 1×
“Thus, OLE supplementation may improve insulin sensitivity and glucose uptake via interleu kin-6, and possible mechanisms for this effect have be n proposed [29], [30].”
BackgroundSystematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes
Yeh, G. Y., Eisenberg, D. M., Kaptchuk, T. J., & Phillips, R. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1277 · Cited by 861
Wühl, E., Witte, K., Soergel, M., Mehls, O., & Schaefer, F. (2002) · Journal of Hypertension · doi:10.1097/00004872-200210000-00019 · Cited by 816
Medicine in Europe: Complementary medicine in Europe
Fisher, P., & Ward, A. (1994) · BMJ · doi:10.1136/bmj.309.6947.107 · Cited by 762
Mediterranean diet and public health: personal reflections
Keys, A. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.6.1321s · Cited by 528
Cited by
Rodriguez-Mateos, A., Vauzour, D., Krueger, C. G., Shanmuganayagam, D., Reed, J., Calani, L., Mena, P., Del Rio, D., & Crozier, A. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1330-7 · Cited by 602
Polyphenols and Glycemic Control
Kim, Y., Keogh, J., & Clifton, P. (2016) · Nutrients · doi:10.3390/nu8010017 · Cited by 548
Hydroxytyrosol, Tyrosol and Derivatives and Their Potential Effects on Human Health
Karković Marković, A., Torić, J., Barbarić, M., & Jakobušić Brala, C. (2019) · Molecules · doi:10.3390/molecules24102001 · Cited by 536
Healthy Effects of Plant Polyphenols: Molecular Mechanisms
Leri, M., Scuto, M., Ontario, M. L., Calabrese, V., Calabrese, E. J., Bucciantini, M., & Stefani, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041250 · Cited by 435
Bulotta, S., Celano, M., Lepore, S. M., Montalcini, T., Pujia, A., & Russo, D. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0219-9 · Cited by 397
Romani, A., Ieri, F., Urciuoli, S., Noce, A., Marrone, G., Nediani, C., & Bernini, R. (2019) · Nutrients · doi:10.3390/nu11081776 · Cited by 394
Mediterranean diet and health status: Active ingredients and pharmacological mechanisms
Schwingshackl, L., Morze, J., & Hoffmann, G. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14778 · Cited by 336
Hydroxytyrosol: Bioavailability, toxicity, and clinical applications
Robles-Almazan, M., Pulido-Moran, M., Moreno-Fernandez, J., Ramirez-Tortosa, C., Rodriguez-Garcia, C., Quiles, J. L., & Ramirez-Tortosa, M. (2018) · Food Research International · doi:10.1016/j.foodres.2017.11.053 · Cited by 318
Guasch-Ferré, M., Merino, J., Sun, Q., Fitó, M., & Salas-Salvadó, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6723931 · Cited by 297
Rigacci, S., & Stefani, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060843 · Cited by 290
Traditional Uses, Phytochemistry, and Pharmacology of Olea europaea(Olive)
Hashmi, M. A., Khan, A., Hanif, M., Farooq, U., & Perveen, S. (2015) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2015/541591 · Cited by 275
Olive by-products: Challenge application in cosmetic industry
Rodrigues, F., Pimentel, F. B., & Oliveira, M. B. P. P. (2015) · Industrial Crops and Products · doi:10.1016/j.indcrop.2015.03.027 · Cited by 227
Tresserra-Rimbau, A., Guasch-Ferré, M., Salas-Salvadó, J., Toledo, E., Corella, D., Castañer, O., Guo, X., Gómez-Gracia, E., Lapetra, J., Arós, F., et al. (2016) · The Journal of Nutrition · doi:10.3945/jn.115.223610 · Cited by 145
“The supplementation improved insulin sensitivity and pancreatic b cell secretory capacity (40).”
BackgroundMuscogiuri, G., Barrea, L., Di Somma, C., Altieri, B., Vecchiarini, M., Orio, F., Spinosa, T., Colao, A., & Savastano, S. (2019) · Hormones · doi:10.1007/s42000-018-0090-9 · Cited by 48
Anti-diabesity middle eastern medicinal plants and their action mechanisms
Saad, B., Kmail, A., & Haq, S. Z. H. (2022) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2022/2276094 · Cited by 42
Metadata
- Authors
- de Bock, M., Derraik, J. G. B., Brennan, C. M., Biggs, J. B., Morgan, P. E., Hodgkinson, S. C., Hofman, P. L., & Cutfield, W. S.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-03-13
- Volume
- 8
- Issue
- 3
- Pages
- e57622
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2154031058
- Cited by
- 306
- References
- 33
- FWCI
- 15.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.